LUBRIS LLC has a total of 70 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are MONDOBIOTECH AG, SEINFELD HUGO and AUSPITZ BENJAMIN A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | Japan | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Australia | 6 | |
#6 | Canada | 5 | |
#7 | Singapore | 4 | |
#8 | China | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Brazil | 2 | |
#11 | Chile | 2 | |
#12 | Israel | 2 | |
#13 | Mexico | 2 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Hong Kong | 1 | |
#16 | Philippines | 1 | |
#17 | Tunisia | 1 | |
#18 | Taiwan | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Fermentation | |
#5 | Preservation of human bodies | |
#6 | Specific use of cosmetics | |
#7 | Object sterilising | |
#8 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Jay Gregory D | 32 |
#2 | Schmidt Tannin | 21 |
#3 | Schmidt Tannin Avery | 21 |
#4 | Truitt Edward R | 20 |
#5 | Krawetz Roman | 19 |
#6 | Sullivan Benjamin D | 18 |
#7 | Elsaid Khaled | 16 |
#8 | Fareed Jawed | 15 |
#9 | Sullivan Benjamin | 14 |
#10 | Szmydynger-Chodobska Joanna | 10 |
Publication | Filing date | Title |
---|---|---|
WO2020247440A1 | Use of prg4 to treat cancer | |
TW202017587A | Lubricin for use in wound healing | |
US2018161393A1 | Prg4 for treating gout and its symptoms | |
US2017312335A1 | Topical use of prg4 for treatment of allergy and symptoms of inflammation | |
US2018140546A1 | Use of prg4 to improve dynamic visual acuity and higher order aberrations | |
MX2017009723A | Use of prg4 as an anti-inflammatory agent. | |
WO2015081121A1 | Compositions and methods for inhibiting intercellular interactions | |
WO2015060935A1 | Control of rheological properties of mixed hyaluronate/lubricin solutions | |
EP2525805A2 | Oral care compositions and methods | |
EP2464375A2 | Prg4 treatment for interstitial cystitis | |
EP2381957A2 | Therapeutic modulation of vaginal epithelium boundary lubrication |